Skip to content
OpenCapital
Get started

Achieve Life Sciences ACHV EPS (Diluted)

EPS (Diluted) at other companies

Pfizer logo
PfizerPFE
$0.47-9.6%
Sionna Therapeutics, Inc. Common Stock logo
Sionna Therapeutics, Inc. Common StockSION
-$0.60+3.2%
Philip Morris International logo
Philip Morris InternationalPM
$1.56-9.3%

Other financials

Income statement

See full
Net income-$10.2M+20.7%

Balance sheet

See full
Cash & equivalents$28.1M+116%
Total debt$5.6M+332%
Total equity$10.7M+3.9%
Total assets$33.1M+21.0%

Cash flow

See full
Operating cash flow-$6.9M+37.5%
CapEx$750.0—
Free cash flow-$12.4M—

Valuation

See full
Market cap$585.16M+404%
Enterprise value$562.71M+439%

Returns & leverage

See full
Return on equity-496.1%-906pp
Debt / equity0.5×+0.4×
Current ratio2.6×-0.9×

Where this comes from

Reported directly by Achieve Life Sciences in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: Achieve Life Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Achieve Life Sciences's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Achieve Life Sciences's EPS (diluted)?
Achieve Life Sciences (ACHV) reported EPS (diluted) of -$0.19 in Q1 2026.
How has Achieve Life Sciences's EPS (diluted) changed year-over-year?
Achieve Life Sciences's EPS (diluted) increased by 48.6% year-over-year, from -$0.37 to -$0.19.
What is the long-term trend for Achieve Life Sciences's EPS (diluted)?
Over 4 years (2021 to 2025), Achieve Life Sciences's EPS (diluted) has grown at a -26.1% compound annual growth rate (CAGR), from -$4.30 to -$1.28.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.